Hatch-Waxman 101

The Hatch-Waxman Act was enacted by Congress to encourage innovation in pharmaceutical research and development, and shorten the time to market for generic drugs. Fish’s award-winning life sciences practice has developed a four-part webinar series to examine and explain the Act in detail.

Chad Shear, an experienced life sciences trial lawyer, presented the first program in the series, Hatch-Waxman 101.

• Introduce the Hatch-Waxman Act;
• Explore the policy underpinning the Act;
• Discuss the approval process and requirements; and
• Examine how exclusivity works.

This complimentary webinar is perfect for those who have limited experience with the Hatch-Waxman Act. It will become the foundation for more advanced discussions in subsequent webinars in the series.

To download the PDF slides of this presentation, click here.

If you have questions, please contact Jane Lundberg at [email protected].